Today, the American Cancer Society Cancer Action Network (ACS CAN) submitted a letter to the Centers for Medicare and Medicaid Services (CMS) commenting on draft guidance related to the maximum monthly cap on patient co-payments under prescription drug plans, referred to as the Medicare Prescription Payment Plan, which will begin in plan year 2025.
MINNEAPOLIS, Minn. – Emily Myatt was recognized as the country’s top government relations professional by the American Cancer Society Cancer Action Network (ACS CAN) in honor of her exceptional work advocat
The American Cancer Society Cancer Action Network (ACS CAN), ACS’ advocacy affiliate, continues to promote policies that expand sustainable access to patient navigation to better support cancer patients. As part of this effort, ACS CAN is urging CMS to finalize a proposed policy as part of a recent payment rule that would allow Medicare to implement a reimbursement strategy that will ensure payment for patient navigation services delivered by professionally trained and certified navigators. ACS CAN also joined with patient and provider groups in a second letter to emphasize the critical importance of navigation reimbursement to facilitating this critical service.
Late Friday, the American Cancer Society Cancer Action Network (ACS CAN) issued a letter to the Department of Health and Human Services, U.S. Department of Labor and Internal Revenue Service commenting on the short-term, limited duration (STLD) insurance rule proposed by the Tri-Agencies in July.
Late Friday, the American Cancer Society Cancer Action Network (ACS CAN) issued a letter to the Centers for Medicare and Medicaid Services (CMS) commenting on the proposed rule for the 2024 Medicare Physician Fee Schedule.
Today, the Biden Administration released the first list of 10 drugs for Medicare price negotiation, including Imbruvica, a cancer drug used to treat certain types of leukemia and lymphoma.
More than 300,000 individuals were disenrolled from the state Medicaid program since the state began its Medicaid redetermination process four months ago, which includes 15,000 newborns removed since Arkansas resumed eligibility reviews in Medicaid following the end of the COVID-19 pandemic.
Today, the Centers for Medicare and Medicaid Services (CMS) released the first monthly data report on the unwinding of Medicaid continuous coverage following the expiration of pandemic-era protections that prompted an eligibility redetermination process led by state agencies.
Yesterday, First Lady Dr. Jill Biden held a call with cancer advocacy organizations to discuss the administration’s commitment to increase access to patient navigation services through reimbursement in Medicare.